XBiotech Inc.
Edit Page
Report
Scan day: 17 February 2014 UTC
45
Virus safety - good
Description: Company focused on the discovery and commercialization of true human monoclonal antibodies.
Improving the Lives of Patients A Pivotal Phase III Registration Study is Underway for Treatment of Colorectal Cancer with Associated Cachexia after Receiving Fast Track Designation by the US FDA Approval for a Pivotal Phase III Registration Study for Treatment of Colorectal Cancer has been Granted by the European Medicines Agency (EMA)
Size: 338 chars
Contact Information
Email: —
Phone&Fax: —
Address: —
Extended: —
WEBSITE Info
| Page title: | Home | XBiotech |
| Keywords: | Your keywords |
| Description: | Your description |
| IP-address: | 72.167.232.117 |
WHOIS Info
| NS | Name Server: NS51.DOMAINCONTROL.COM Name Server: NS52.DOMAINCONTROL.COM |
| WHOIS | Status: clientDeleteProhibited Status: clientRenewProhibited Status: clientTransferProhibited Status: clientUpdateProhibited |
| Date | Creation Date: 21-oct-2002 Expiration Date: 01-jul-2018 |